Hospital
Copiah County Medical Center
Copiah County Medical Center was paid $9.87M by Medicaid between Jan 2018 and Dec 2024, across 121 billing codes. Its largest line is 99284, emergency room visit (serious) — 25% of everything it billed.
33Billing provider infoCOPIAH COUNTY MEDICAL CENTER
HAZLEHURST, MS 39083
HAZLEHURST, MS 39083
33aNPI1588667281assigned 05/27/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$9.87M
24GClaims214,962
24DCodes billed121
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#36 of 77
Median peer was paid$8.23M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,816 | $1.19M | |
| 2019 | 40,612 | $1.55M | |
| 2020 | 19,926 | $1.07M | |
| 2021 | 29,186 | $1.47M | |
| 2022 | 38,004 | $1.71M | |
| 2023 | 33,853 | $1.71M | |
| 2024incomplete | 24,565 | $1.16M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 12,411 | 10,054 | $2.43M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 6,342 | 5,088 | $1.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 10,105 | 8,407 | $1.47M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.6% | 4,644 | 3,575 | $356K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.5% | 4,200 | 3,453 | $344K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.3% | 8,116 | 6,448 | $327K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 3,247 | 2,356 | $284K |
| 71045 | Radiologic examination, chest; single view | 2.5% | 6,369 | 4,967 | $250K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 2.5% | 2,794 | 2,159 | $244K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.3% | 2,810 | 1,540 | $231K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.1% | 2,675 | 2,158 | $210K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 756 | 629 | $193K |
109 more codes
| G0378 | Hospital observation service, per hour | 1.8% | 438 | $175K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 5,550 | $126K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.2% | 3,169 | $119K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 771 | $114K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.1% | 3,782 | $112K |
| 93041 | 1.1% | 4,264 | $108K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 8,827 | $105K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 2,931 | $97K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,068 | $96K |
| 80053 | Comprehensive metabolic panel | <1% | 11,209 | $89K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 2,598 | $83K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 13,355 | $65K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 1,118 | $58K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,115 | $58K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,257 | $52K |
| 83880 | <1% | 2,280 | $43K | |
| 80306 | <1% | 3,254 | $35K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,358 | $35K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 1,363 | $34K |
| 94799 | <1% | 1,089 | $33K | |
| 84484 | <1% | 4,935 | $30K | |
| 81025 | <1% | 3,912 | $26K | |
| 51702 | <1% | 549 | $25K | |
| 81001 | <1% | 9,579 | $22K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,012 | $18K |
| 36600 | <1% | 427 | $17K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 638 | $17K |
| 74018 | <1% | 374 | $15K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 424 | $15K |
| 87420 | <1% | 1,208 | $14K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 285 | $14K |
| 82553 | <1% | 1,695 | $11K | |
| 73560 | <1% | 247 | $10K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 116 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,649 | $9K |
| 82550 | <1% | 1,894 | $8K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,494 | $8K |
| 83735 | <1% | 2,265 | $8K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,509 | $8K |
| 83874 | <1% | 919 | $7K | |
| 83605 | <1% | 1,138 | $7K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 319 | $7K |
| 83690 | <1% | 1,379 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,051 | $6K |
| 82803 | <1% | 438 | $6K | |
| 85379 | <1% | 838 | $5K | |
| 73630 | <1% | 77 | $4K | |
| 87040 | <1% | 740 | $4K | |
| 94664 | <1% | 1,284 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 3,201 | $4K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 22 | $4K |
| 73610 | <1% | 66 | $3K | |
| 11721 | <1% | 167 | $3K | |
| 36416 | <1% | 969 | $3K | |
| 82150 | <1% | 690 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 41 | $3K |
| 73030 | <1% | 78 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 542 | $3K |
| 80061 | Lipid panel | <1% | 305 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 207 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 58 | $2K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $1K |
| 96376 | <1% | 186 | $1K | |
| 99221 | <1% | 89 | $1K | |
| 73130 | <1% | 22 | $1K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 87 | $893.88 |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 49 | $798.52 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 256 | $735.59 |
| 85610 | <1% | 352 | $732.18 | |
| 85730 | <1% | 250 | $719.55 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 639 | $683.55 |
| 71250 | <1% | 13 | $639.44 | |
| 87400 | <1% | 63 | $632.19 | |
| 01992 | <1% | 30 | $605.15 | |
| J3490 | Unclassified drugs | <1% | 649 | $547.48 |
| 86677 | <1% | 51 | $473.15 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 1,290 | $421.42 |
| 87430 | <1% | 32 | $409.66 | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 69 | $400.66 |
| 84703 | <1% | 55 | $397.25 | |
| 84520 | <1% | 99 | $386.72 | |
| 82565 | <1% | 98 | $277.78 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 20 | $265.26 |
| 87070 | <1% | 13 | $264.52 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 16 | $238.42 |
| 84439 | <1% | 27 | $228.15 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 627 | $169.88 |
| J1815 | Injection, insulin, per 5 units | <1% | 126 | $144.37 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 75 | $77.71 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 475 | $59.57 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 42 | $53.89 |
| 82607 | <1% | 13 | $47.04 | |
| J7510 | Prednisolone oral, per 5 mg | <1% | 502 | $36.26 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 14 | $28.00 |
| 80320 | <1% | 62 | $23.30 | |
| J2780 | Injection, ranitidine hydrochloride, 25 mg | <1% | 33 | $18.01 |
| 90715 | <1% | 44 | $17.84 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 16 | $15.84 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 108 | $11.80 |
| 81015 | <1% | 16 | $8.25 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 29 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 111 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 68 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 32 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 0% | 22 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 16 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 14 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 20 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGADDY, KORTNEY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Copiah County Medical Center | Hazlehurst, MS | $2.39M |
| Copiah County Medical Center | Crystal Springs, MS | $686K |
| Copiah County Medical Center | Wesson, MS | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.